Internal Medicine, Infectious Disease · Merced, CA
NPI
1043204605
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
3389 G St, Suite A
Merced, CA, 95340
Phone (209) 722-1205
Groups this clinician bills Medicare through
Medicare paid, 2024
$190K
3,463 services
Medicare patients, 2024
582
Average age 75
Drug cost, 2024
$1.6M
8,040 prescriptions
Company payments, 2025
$595
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicolas R Delapena was code 99232 (hospital e&m - subsequent), 1,454 times for 251 patients. In total Nicolas R Delapena billed 3,463 services in 11 codes, and Medicare paid $190K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,454 | 251 | $56.61 | $82K |
| 99213 Office E&M - Established | Office | 1,406 | 331 | $46.66 | $66K |
| 99222 Hospital E&M - Initial | Facility | 294 | 259 | $88.99 | $26K |
| 99214 Office E&M - Established | Office | 190 | 143 | $48.98 | $9,307 |
| 99308 SNF E&M | Facility | 50 | 11 | $45.51 | $2,276 |
| 99212 Office E&M - Established | Office | 40 | 33 | $38.38 | $1,535 |
| 99204 Office E&M - New | Office | 18 | 18 | $105.39 | $1,897 |
By year: 2022 $262K for 4,556 services; 2023 $254K for 4,296 services; 2024 $190K for 3,463 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicolas R Delapena prescribed most often to Medicare patients was Losartan Potassium, with 337 prescriptions and refills. In total Nicolas R Delapena wrote 8,040 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 337 | 890 | 91 | $3,570 |
| Levothyroxine Sodium Generic | 321 | 797 | 77 | $3,544 |
| Atorvastatin Calcium Generic | 260 | 702 | 68 | $2,873 |
| Metoprolol Succinate Generic | 240 | 661 | 69 | $4,576 |
| Pantoprazole Sodium Generic | 198 | 475 | 61 | $2,370 |
| Gabapentin Generic | 195 | 351 | 52 | $2,795 |
| Simvastatin Generic | 181 | 515 | 55 | $1,413 |
| Tramadol Hcl Generic | 179 | 186 | 36 | $1,002 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 165 | 165 | 37 | $4,543 |
| Lorazepam Generic | 160 | 164 | 30 | $820 |
| Carvedilol Generic | 158 | 403 | 39 | $1,204 |
| Amlodipine Besylate Generic | 151 | 418 | 48 | $1,506 |
| Lisinopril Generic | 126 | 361 | 34 | $1,073 |
| Escitalopram Oxalate Generic | 124 | 219 | 24 | $1,279 |
| Omeprazole Generic | 124 | 330 | 40 | $1,761 |
Brand drugs: 1,192 claims; generic drugs: 6,750 claims; opioid claims: 386.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicolas R Delapena $595 ($595 in general payments such as food, travel and fees) from 7 companies. The largest payer was Astellas Pharma US Inc with $230.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.